369
Participants
Start Date
June 30, 2015
Primary Completion Date
May 31, 2017
Study Completion Date
May 31, 2017
Placebo
2 weeks of placebo PO daily
Fimasartan
60mg 1 tab PO daily for 2 weeks and 120mg 1 tab PO daily for 4 weeks
Valsartan
80mg 1 tab PO daily for 2 weeks and 160mg 1 tab PO daily for 4 weeks
Olmesartan medoxomil
10mg 1 tab PO daily for 2 weeks and 20mg 1 tab PO daily for 4 weeks
The Catholic University of Korea, Seoul St.Mary's Hospital, Seoul
The Catholic University of Korea, Incheon St.Mary's Hospital, Incheon
The Catholic University of Korea, St. Paul's Hospital, Seoul
The Catholic University of Korea, Bucheon St.Mary's Hospital, Bucheon-si
The Catholic University of Korea, St.Vincent's Hospital., Suwon
The Catholic University of Korea,Uijeongbu St.Mary's Hospital, Uijeongbu-si
The Catholic University of Korea, Daejeon St. Mary's Hospital, Daejeon
The Catholic University of Korea,Yeouido St.Mary's Hospital, Seoul
Lead Sponsor
Boryung Pharmaceutical Co., Ltd
INDUSTRY